Black patients with multiple myeloma waited an average of four months longer than White patients for a hematopoietic stem cell transplant, according to a study of 495 patients treated by the Moffitt Cancer Center inf Florida. The transplant is an infusion of healthy stem cells after chemotherapy to reestablish the blood cell production process in the bone marrow.
Despite the longer wait, however, Black patients survived just as long as White and Hispanic patients.
“Studies show that with similar access to care and novel treatment utilization, clinical outcomes are similar across racial and ethnic groups, with some studies suggesting slightly improved outcomes for Black patients,” the study authors noted.
- See “Molecular Features May Contribute to Racial/Ethnic Disparities in Multiple Myeloma” by Leah Lawrence on the Cancer Therapy Advisor website (July 7, 2022)
- See the full text of the scientific paper “Racial and ethnic differences in clonal hematopoiesis, tumor markers, and outcomes of patients with multiple myeloma” by Lauren C Peres et al.
Related posts of interest
